Kelly Morgan

Senior Vice President

Professional Overview

Kelly Morgan is an accomplished legal and corporate affairs executive with over 15 years of experience driving strategic initiatives and delivering business-critical solutions for innovative biotechnology companies. As the Senior Vice President at Ring Therapeutics, she leverages her deep expertise in legal, regulatory, and governance domains to support the company's mission of advancing transformative gene therapy technologies.

Experience Summary

Current Role

As the Senior Vice President at Ring Therapeutics, Kelly is responsible for overseeing the organization's legal, compliance, and corporate governance functions. She provides strategic counsel to the executive team, advises on complex transactions and collaborations, and ensures adherence to regulatory requirements. Under her leadership, Ring Therapeutics has navigated critical milestones, including the successful completion of multiple financing rounds and the advancement of the company's pipeline of novel gene therapy candidates.

Career Progression

Prior to joining Ring Therapeutics, Kelly served as the Senior Vice President, Head of Legal and Corporate Secretary at Arbor Biotechnologies, where she played a pivotal role in shaping the company's legal and corporate strategy during a period of rapid growth. She has also held roles as Counsel at Flagship Pioneering, a leading life sciences venture capital firm, and as an Associate at Saul Ewing LLP, where she gained valuable experience in patent law and corporate transactions.

Academic Background

Kelly holds a Juris Doctor (J.D.) from the University of Minnesota Law School and a Bachelor of Science in Biology from the University of Minnesota. She is a licensed patent agent and has been recognized for her outstanding academic achievements, including being named to the Dean's List during her time in law school.

Areas of Expertise

• Legal and regulatory compliance

• Corporate governance

• Intellectual property strategy

• Licensing and collaboration negotiations

• Mergers, acquisitions, and financing transactions

• Biotechnology and life sciences industry expertise

Professional Impact

Throughout her career, Kelly has played a pivotal role in supporting the growth and success of innovative biotechnology companies. At Arbor Biotechnologies, she was instrumental in securing critical financing and establishing strategic partnerships that enabled the company to advance its gene editing platform. At Ring Therapeutics, she has been a driving force behind the organization's legal and corporate initiatives, contributing to the advancement of its gene therapy pipeline and the company's overall expansion.

Conclusion

With her extensive legal expertise, deep industry knowledge, and proven track record of driving strategic initiatives, Kelly Morgan is poised to continue making a significant impact in the biotechnology sector. As the Senior Vice President at Ring Therapeutics, she is committed to supporting the company's mission of transforming patient lives through the development of groundbreaking gene therapy solutions.